Conclusion JAK2 exon 12 mutations could exist in JAK2V617F-negative PV patients.
结论JAK2V 617 F点突变阴性的PV患者中存在JAK2外显子12突变。
JAK2 is a constitutive protein tyrosine kinase (PTK) which can activate JAK-STAT signaling.
JAK2是一种组成性酪氨酸激酶,能激活JAK - STAT信号传导途径。
"Those children at the highest risk for leukemia may be treated with inhibitors of JAK2," he says.
他说:“这些患有高致命性白血病的儿童可以用JAK2抑制剂进行治疗。”
应用推荐